Belgravia Hartford Announces USD$5M Convertible Secured Debenture with Round13 DAF & Closing of C$4M Private Placement
BELGRAVIA HARTFORD CAPITAL INC. (CSE:BLGV)(OTC:BLGVF)(FRA:ECA) ("Company" or “Belgravia”) is pleased to announce that:
- it has entered into a binding agreement with Round13 Digital Asset Fund (“Round13 DAF”) for a secured convertible debenture for a one-time principal amount investment of USD$5,000,000 (the “Debenture”) convertible into common shares at C$0.71, being a 40% premium to the volume-weighted average trading price (the “VWAP”) for the seven consecutive days immediately preceding the date of this announcement; and
- as a result of this above-market Debenture, Belgravia has elected to voluntarily reduce its non-brokered private placement to close on 16,091,822units (the “Units”) at a price of C$0.25 per Unit for aggregate gross proceeds of C$4,022,955.55(the “Offering”) to the Company.
New USD$5 Million Round13 DAF Debenture Convertible at C$0.71
The principal amount and interest of the Debenture is convertible into common shares of Belgravia at a conversion price (the “Conversion Price”) of C$0.71, being a 40% premium to the VWAP for the seven consecutive days immediately preceding the date of this announcement. In the case that, at any time prior to the maturity date of the Debenture, the VWAP of Belgravia common shares equals or exceeds C$1.42, being 200% of the Conversion Price for 20-consecutive trading days of the common shares on the Canadian Securities Exchange (the “CSE”), then 20% of the then-outstanding principal amount (together with a proportionate amount of accrued and unpaid interest) shall automatically convert into common shares of Belgravia without any further action of Round13 DAF. The Debenture bears interest at a rate of 4% per annum, accrued monthly, and matures two years from the closing date thereof.
Mehdi Azodi, CEO of Belgravia stated: “This continued support from Round13 DAF, our lead strategic advisor and partner in all areas of Bitcoin-related finance, results in any new securities issued being set at a 40% premium to the price of Belgravia shares for the seven consecutive days immediately preceding the date of the announcement – a far less dilutive mechanism for Belgravia to achieve its stated goals. In addition, as a result of this Debenture, Belgravia has determined that it is in the best interests of our shareholders, to voluntarily cap the Offering at slightly more than 40% of its initial size”.
Mehdi Azodi continued: “This path enables Belgravia to achieve an excess amount of additional Bitcoin than originally expected to our treasury but, most importantly, with almost 60% less dilution.”
Khaled Verjee, Managing Director of Round13 DAF added: “We are extremely pleased to continue to support our partners and believe Belgravia is building an innovative business where Bitcoin treasury strategies play an integral role. From its innovative capital structures, protecting shareholder value, to its suite of, soon to be launched, Bitcoin focused technical tools designed to increase shareholder value and growth at a BTC level, Belgravia is well-positioned in this space. For a microcap to be thinking the way Belgravia is, and to have the technical team it does, it is in our opinion a recipe for long term success”.
Closing of Offering
As disclosed by press release on June 24, 2025, the Company announced a non-brokered private placement of Units. Under the Offering, each Unit consists of one common share of the Company (a “CommonShare”) and one-half of one Common Share purchase warrant (each whole warrant, a “Warrant”) at a price of C$0.25 per Unit. Each Warrant entitles the holder to acquire one additional Common Share at an exercise price of C$0.50 per share for a period of 12-months from the date of issuance. The Warrants will be subject to an acceleration clause whereby, if the closing price of the Common Shares on the CSE is greater than C$0.75 for a period of ten consecutive trading days, the Company may accelerate the expiry date of the Warrants by giving notice to the holders thereof. In such case, the Warrants will expire 30-days after the date of such notice. Under the Offering, a total of 16,091,822Units were issued at a price of C$0.25 per Unit for aggregate gross proceeds of C$4,022,955.55.
No finders fees or commissions were paid to any party in connection with either the Offering or the Debenture.
In accordance with the policies of the CSE and applicable securities legislation,the Common Shares and Warrants comprising the Units will be subject to a hold period of four months and one day from the date of issuance. In addition, closing of the Debenture is subject to all rules, policies and procedures of the CSE.
Belgravia intends to use the proceeds of the Debenture and the Offering to purchase Bitcoin, in line with the Company’s strategic objective of building a 100% Bitcoin only Treasury.
For more information, legal disclaimer and about Belgravia Hartford please visit, please visit www.belgraviahartford.com or www.blgvbtc.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250715265083/en/
Contacts
For More Information, Please Contact:
Mehdi Azodi, President & CEO
Belgravia Hartford Capital Inc.
(416) 779-3268
mazodi@blgv.ca
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Economics17.7.2025 15:05:00 EEST | Press release
With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies – Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoimmune diseases, and other complex indications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250717625155/en/ In Vivo Car T Infographic from Novotech Traditional ex-vivo CAR-T therapies require extracting a patient’s T cells, engineering them in specialized labs, and reinfusing them, a process that is time-intensive, expensive, and logistically complex. These barriers have significantly restricted patient access. In contrast, in-vivo CAR-T the
SBC Medical Group Acquires MB Career Lounge: “JUN CLINIC” Joins the Group, Strengthening Competitive Position in a Growing Market17.7.2025 15:00:00 EEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global franchise and provider of services for aesthetic clinics, announced that, on July 17, 2025, it acquired MB career lounge, Co., Ltd. (“MB career lounge”), a privately-held provider of management support services for medical institutions, specializing in consulting, training, and human resources solutions in Japan, through a share purchase transaction for cash consideration. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250717637525/en/ JUN CLINIC Through this transaction, JUN CLINIC, operated by Medical Corporation Misakikai and supported by MB career lounge, will join SBC Medical’s clinic network, contributing to portfolio diversification and is expected to enhance revenue stability. “The surging demand for personalized aesthetic solutions, particularly 'Customized Laser Treatment,' underscores a rapidly expanding market. JUN CL
ExaGrid Recognized on the Prestigious 2025 MES Midmarket 100 List17.7.2025 15:00:00 EEST | Press release
ExaGrid®, the industry’s only Tiered Backup Storage solution with Retention Time-Lock that includes a non-network-facing tier (creating a tiered air gap), delayed deletes and immutability for ransomware recovery, today announced that MES Computing, a brand of The Channel Company, has highlighted ExaGrid on its 2025 MES Midmarket 100 list. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250717959869/en/ The annual MES Midmarket 100 recognizes technology vendors with deep knowledge of the unique IT needs of midmarket organizations. These vendors are committed to delivering future-focused products and services that support growth, innovation, and success for their midsize customers. MES Computing defines midmarket organizations as those with an annual revenue of $50 million to $2 billion and/or 100 to 2,500 total supported users/seats. Vendors were selected for the MES Midmarket 100 for their go-to-market strategy, how they inno
Ant International Expands Merchant Payment AI Functions With Antom Copilot 2.017.7.2025 14:28:00 EEST | Press release
Antom, Ant International’s merchant payment and digitisation services provider, today announced a major upgrade to its flagship AI agent, Antom Copilot, with expanded capabilities across payment integration, onboarding, risk configuration, and chargeback solution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250717902855/en/ Antom Copilot 2.0 equips merchants with AI-powered chargeback management and win-rate predictions through an integrated dashboard interface Antom Copilot is the world’s first merchant payment service AI agent, launched in June 2024. It’s built on Ant International’s Alipay+ GenAI Cockpit, an AI-as-a-Service (AIaaS) platform that enables fintech companies and super apps to build AI-agentic and ultimately AI-native financial services. Nearly 50% of SME clients of Antom do not actively respond to chargebacks. An industry first, the Chargeback AI Assistant offers a faster and more effective solution to the
Kinaxis Inc. to Host Second Quarter 2025 Financial Results Conference Call on August 7, 202517.7.2025 14:00:00 EEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its second quarter ended June 30, 2025. The call will be hosted on Thursday, August 7 at 8:30 a.m. Eastern Time by Bob Courteau, interim chief executive officer and chair, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the second quarter after the close of markets on Wednesday, August 6, 2025. CONFERENCE CALL DETAILS DATE:Thursday, August 7, 2025TIME: 8:30 a.m. Eastern Time CALL REGISTRATION: https://registrations.events/direct/Q4I9141647WEBCAST: https://events.q4inc.com/attendee/980400584 (available for three months) Advance call registration Participants must register in advance for the live call. After registering, instructions on how to join the call will automatically be emailed, including dial-in information as we
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom